about
Genetics and neuropathology of Huntington's diseaseSleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's diseaseInduction of neostriatal neurogenesis slows disease progression in a transgenic murine model of Huntington diseaseNeurocardiovascular deficits in the Q175 mouse model of Huntington's disease.Huntington's disease (HD): degeneration of select nuclei, widespread occurrence of neuronal nuclear and axonal inclusions in the brainstem.Baroreceptor reflex dysfunction in the BACHD mouse model of Huntington's diseaseProteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules.Cardiac Dysfunction in the BACHD Mouse Model of Huntington's Disease.Striatal neuronal loss correlates with clinical motor impairment in Huntington's disease.RAN Translation in Huntington Disease.Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cellsStudies on free radicals, antioxidants, and co-factorsCommentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges.Clinical and genetic investigation of a Brazilian family with Huntington's disease.Huntington's disease (HD): the neuropathology of a multisystem neurodegenerative disorder of the human brain.Template-directed ligation on repetitive DNA sequences: a chemical method to probe the length of Huntington DNA.Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease.Huntington's Disease: Characteristics of Fallers.Degeneration of the cerebellum in Huntington's disease (HD): possible relevance for the clinical picture and potential gateway to pathological mechanisms of the disease process.Huntington Disease: Molecular Diagnostics Approach.Use of capillary electrophoresis for accurate determination of CAG repeats causing Huntington disease. An oligonucleotide design avoiding shadow bands.Detection of mutations by flow cytometric melting point analysis of PCR products.
P2860
Q27023050-F72A2865-0144-4EE9-8FE7-0C0714F96765Q28383062-2D5AE7B1-2328-44FF-9053-3C986F95FAFDQ30480065-CD699A25-F9A2-4BC5-9C44-067F5288D1BDQ33800209-39E23920-6E59-4C45-8931-994C590A7E52Q34162629-28187E8F-D91B-4A27-856F-5F21DD92A914Q35526470-D46B1E54-C7B4-4A8D-8AB0-A64884C17540Q35879035-094C4039-190A-4D1C-A308-1DEF73C1AD87Q35903061-C859DB71-90D2-4BDE-B26A-81C8DF9DAD97Q36269123-165616C5-47CD-4D6D-B68B-F706FF925322Q36386897-F8C4F852-FB1F-44EC-8B33-518AF8CBBDA4Q36423519-7B518B72-2597-4272-BEC0-2884E31D84DBQ37017403-88A1B8E4-69BC-4A85-972B-9B4361302BFCQ37352376-2AFD4ACF-9211-4CB7-8BB8-4C36FBD6649AQ37422838-476E4583-A8CA-4638-BA1E-270C2568456AQ39193175-9DDBF111-6DEC-46B4-B14A-24815F142B10Q40980119-FE158AEF-09A5-49BA-B3E2-44A289513410Q42130111-131C3666-BEC8-4AEF-ADDF-CF422C6DB90AQ44032095-28C9677D-75E9-48EB-8F85-7D1E07F5665FQ45289712-A75B6465-376F-404D-814E-037ADC931AF6Q45290471-6A3CF20B-E289-42F1-A875-FCF897B43E6AQ45293462-D8D04A21-6F5E-4A06-922D-B972875265DFQ45303666-7FFD9667-7D2C-429C-81F1-EC92619F5CD3
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Diagnosis of Huntington disease.
@ast
Diagnosis of Huntington disease.
@en
type
label
Diagnosis of Huntington disease.
@ast
Diagnosis of Huntington disease.
@en
prefLabel
Diagnosis of Huntington disease.
@ast
Diagnosis of Huntington disease.
@en
P356
P1433
P1476
Diagnosis of Huntington disease.
@en
P2093
Russell L Margolis
P304
P356
10.1373/49.10.1726
P407
P577
2003-10-01T00:00:00Z